Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05922> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05922 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05922 label "Hedgehog pathway inhibitor [drugbank:DB05922]" assertion.
- drugbank:DB05922 seeAlso DB05922 assertion.
- drugbank:DB05922 description "Hedgehog pathway inhibitor(Cyclopamine) is naturally occuring steroidal alkaloid that causes cyclopia by blocking sonic hedgehog signaling. Cyclopamine is currently being investigated as a treatment agent in basal cell carcinoma, medulloblastoma, and rhabdomyosarcoma, tumors that result from excessive Hh activity, glioblastoma, and as a treatment agent for multiple myeloma. It is currently under phase I of clinical trial." assertion.
- drugbank:DB05922 identifier "drugbank:DB05922" assertion.
- drugbank:DB05922 title "Hedgehog pathway inhibitor" assertion.
- drugbank:DB05922 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05922 drugbank_vocabulary:drugbank-id "DB05922" assertion.
- drugbank:DB05922 bio2rdf_vocabulary:x-identifiers.org DB05922 assertion.
- drugbank:DB05922 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05922" assertion.
- drugbank:DB05922 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05922 bio2rdf_vocabulary:identifier "DB05922" assertion.